S2CID 41620120
Orders are processed within 1-2 days
Patients with significant visceral fat burden see the clearest benefit from tesamorelin
Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Image: milorad kravic/Getty Images About the Author Heidi Godman, Managing Director About the Reviewer Anthony L
Its a Vegas buffet of self-quantification: body composition, basal metabolic rate, heart-rate variability, gut microbiome makeup, sleep quality, and other biometrics